Further, correlation of tau PET burden and cognitive performance has been established consistently in sporadic AD (Bucci et al., 2021; Mueller et al., 2020) as well as DS-AD (Rafii et al., 2017; Grigorova et al., 2022), showing a worse performance on neuropsychological assessments with marked tracer binding. This evidence concerns the gene MAPT and Alzheimer disease.